NCT03469375View on ClinicalTrials.gov

Modified-FOLFIRINOX Regimen Based Neoadjuvant Therapy in Chinese Patients With Locally Advanced Pancreatic Cancer

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

April 1, 2014

Primary Completion Date

November 1, 2017

Study Completion Date

November 1, 2017

Conditions

Pancreatic CancerChemotherapy EffectSurgery--Complications

Interventions

DRUG

modified-FOLFIRINOX

LAPC patients with mFOLFIRINOX-based neoadjuvant therapy or not was set as the main intervention

Trial Locations (1)

310009

the second affiliated hospital of Zhejiang University, Hangzhou

All Listed Sponsors

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT03469375 - Modified-FOLFIRINOX Regimen Based Neoadjuvant Therapy in Chinese Patients With Locally Advanced Pancreatic Cancer | Biotech Hunter | Biotech Hunter